DexCom Director Nicholas Augustinos Files Form 144 to Sell $130K in Common Stock
DEXCOM INC
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale: DEXCOM INC ($DXCM) • Insider: Nicholas Augustinos (Director) • Shares to Sell: 1,550 Common Stock • Estimated Market Value: $130,231.00 (~$84.02/share) • Plan Adoption Date: June 10, 2026 (10b5-1 Plan) • Broker: Fidelity Brokerage Services LLC • Filing Date: September 14, 2026
Comprehensive Analysis
Executive Summary
On September 14, 2026, Nicholas Augustinos, a Director at DexCom, Inc. ($DXCM), filed a Form 144 proposing the sale of 1,550 shares of common stock through Fidelity Brokerage Services LLC. The transaction has an aggregate market value of approximately $130,231.00.
Key Transaction Details
- Filer: Nicholas Augustinos (Director)
- Security: Common Stock
- Shares Proposed for Sale: 1,550
- Aggregate Market Value: $130,231.00 (~$84.02 per share)
- Shares Outstanding: 377,360,765
- Acquisition Origin: Vested RSU Grant on May 8, 2026
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2026
Market Impact & Significance
The trading significance is rated Low. The proposed sale represents a negligible fraction of DexCom's total outstanding shares (~0.0004%) and is being executed under a pre-established Rule 10b5-1 trading plan following the vesting of restricted stock units.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.